EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics

Fabian Krutzek iD, Cornelius K Donat, Sven Stadlbauer iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242015088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Fabian Krutzek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Medicinal Radiochemistry, Bautzner Landstraße 4…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitor therapy targeting the PD-1/PD-L1 axis in cancer patients, is a promising oncological treatment. However, the number of non-responders remains high, causing a burden for the patient and the healthcare system. Consequently, a diagnostic tool to predict treatment outcomes would help with patient stratification. Molecular imaging provides said diagnostic tool by offering a whole-body quantitative assessment of PD-L1 expression, hence supporting therapy decisions. Four PD-L1 radioligand candidates containing a linker-chelator system for radiometalation, along with three hydrophilizing units—one sulfonic and two phosphonic acids—were synthesized. After labeling with 64Cu, log D7.4 values of less than −3.03 were determined and proteolytic stability confirmed over 94% intact compound after 48 h. Binding affinity was determined using two different assays, revealing high affinities up to 13 nM. µPET/CT imaging was performed in tumor-bearing mice to investigate PD-L1-specific tumor uptake and the pharmacokinetic profile of radioligands. These results yielded an unexpected in vivo distribution, such as low tumor uptake in PD-L1 positive tumors, high liver uptake, and accumulation in bone/bone marrow and potentially synovial spaces. These effects are likely caused by Ca2+-affinity and/or binding to macrophages. Despite phosphonic acids providing high water solubility, their incorporation must be carefully considered to avoid compromising the pharmacokinetic behavior of radioligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyNeoplasmsHumansAnimalsMicePhosphorous AcidsB7-H1 AntigenRadiopharmaceuticalsCell Line, Tumor

Stichwörter der Autor:innen

PD-L1PET imagingorganic synthesisphosphonic acidsradiotracersstructure-activity relationship

Substanzen

Phosphorous AcidsB7-H1 AntigenRadiopharmaceuticals

Autor:innen und Institutionen

  • Helmholtz Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Medicinal Radiochemistry, Bautzner Landstraße 400, 01328 Dresden, Germany.
  • School of Science, Faculty of Chemistry and Food Chemistry, Technical University Dresden, 01069 Dresden, Germany.

ORCID-Profile: Fabian Krutzek, Sven Stadlbauer

Zitieren

APA

Krutzek, F., Donat, C. K., & Stadlbauer, S. (2023). Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015088

Vancouver

Krutzek F, Donat CK, Stadlbauer S. Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015088

BibTeX
@article{Krutzek2023,
  author = {Krutzek, Fabian and Donat, Cornelius K and Stadlbauer, Sven},
  title = {Exploring Hydrophilic PD-L1 Radiotracers Utilizing Phosphonic Acids: Insights into Unforeseen Pharmacokinetics},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242015088}
}
Kostenlos starten →